169 related articles for article (PubMed ID: 36437949)
1. Integrative multiomics evaluation reveals the importance of pseudouridine synthases in hepatocellular carcinoma.
Jin Z; Song M; Wang J; Zhu W; Sun D; Liu H; Shi G
Front Genet; 2022; 13():944681. PubMed ID: 36437949
[No Abstract] [Full Text] [Related]
2. Comprehensive Analysis of HOX Family Members as Novel Diagnostic and Prognostic Markers for Hepatocellular Carcinoma.
Jin Z; Sun D; Song M; Zhu W; Liu H; Wang J; Shi G
J Oncol; 2022; 2022():5758601. PubMed ID: 35251173
[TBL] [Abstract][Full Text] [Related]
3.
Lan C; Huang X; Liao X; Zhou X; Peng K; Wei Y; Han C; Peng T; Wang J; Zhu G
Pharmgenomics Pers Med; 2023; 16():337-355. PubMed ID: 37091827
[TBL] [Abstract][Full Text] [Related]
4. Pyroptosis related genes signature predicts prognosis and immune infiltration of tumor microenvironment in hepatocellular carcinoma.
Fang G; Zhang Q; Fan J; Li H; Ding Z; Fu J; Wu Y; Zeng Y; Liu J
BMC Cancer; 2022 Sep; 22(1):999. PubMed ID: 36127654
[TBL] [Abstract][Full Text] [Related]
5. A novel machine learning derived RNA-binding protein gene-based score system predicts prognosis of hepatocellular carcinoma patients.
Zhang Q; Zhang Y; Guo Y; Tang H; Li M; Liu L
PeerJ; 2021; 9():e12572. PubMed ID: 35036125
[TBL] [Abstract][Full Text] [Related]
6. N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinoma.
Cai J; Zhou M; Xu J
World J Surg Oncol; 2021 Aug; 19(1):241. PubMed ID: 34389000
[TBL] [Abstract][Full Text] [Related]
7. Identification and Validation of Ubiquitin-Specific Proteases as a Novel Prognostic Signature for Hepatocellular Carcinoma.
Ni W; Bian S; Zhu M; Song Q; Zhang J; Xiao M; Zheng W
Front Oncol; 2021; 11():629327. PubMed ID: 33718205
[TBL] [Abstract][Full Text] [Related]
8. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
Ma C; Kang W; Yu L; Yang Z; Ding T
Front Oncol; 2020; 10():590006. PubMed ID: 33363020
[TBL] [Abstract][Full Text] [Related]
9. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.
Dai K; Liu C; Guan G; Cai J; Wu L
BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis to identify the neurotransmitter receptor-related genes as prognostic and therapeutic biomarkers in hepatocellular carcinoma.
Wang X; Li Y; Shi Y; Luo J; Zhang Y; Pan Z; Wu F; Tian J; Yu W
Front Cell Dev Biol; 2022; 10():887076. PubMed ID: 35990607
[No Abstract] [Full Text] [Related]
11. Identification of a Pyroptosis-Related Prognostic Signature Combined With Experiments in Hepatocellular Carcinoma.
Li H; Li T; Zhang X
Front Mol Biosci; 2022; 9():822503. PubMed ID: 35309514
[TBL] [Abstract][Full Text] [Related]
12. Identification and Validation of Necroptosis-Related LncRNA Signature in Hepatocellular Carcinoma for Prognosis Estimation and Microenvironment Status.
Chen C; Wu Y; Chen K; Xia Z; Liu X; Zhang C; Zhao H; Shen A
Front Genet; 2022; 13():898507. PubMed ID: 35754846
[No Abstract] [Full Text] [Related]
13. Identification of an Endoplasmic Reticulum Stress-Related Gene Signature to Evaluate the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma.
Song D; Zhou Z; Zhang D; Wu J; Hao Q; Zhao L; Ren H; Zhang B
Front Genet; 2022; 13():850200. PubMed ID: 35711939
[TBL] [Abstract][Full Text] [Related]
14. Exonuclease 1 is a Potential Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma.
Ma J; Jin J; Lu H; Zhang J; Li Y; Cai X
Front Mol Biosci; 2022; 9():889414. PubMed ID: 35769911
[No Abstract] [Full Text] [Related]
15. CELSR3 mRNA expression is increased in hepatocellular carcinoma and indicates poor prognosis.
Gu X; Li H; Sha L; Mao Y; Shi C; Zhao W
PeerJ; 2019; 7():e7816. PubMed ID: 31608178
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatics analysis and experimental verification of the prognostic and biological significance mediated by fatty acid metabolism related genes for hepatocellular carcinoma.
Zhu XR; Zhu JQ; Chen YF; Liu YY; Lu JJ; Sun J; Peng SQ; Chen MB; Du YP
Front Oncol; 2022; 12():972744. PubMed ID: 35982956
[TBL] [Abstract][Full Text] [Related]
17. Identification and Validation of Pyroptosis-Related Gene Signature to Predict Prognosis and Reveal Immune Infiltration in Hepatocellular Carcinoma.
Fu XW; Song CQ
Front Cell Dev Biol; 2021; 9():748039. PubMed ID: 34820376
[No Abstract] [Full Text] [Related]
18. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma.
Zhang X; Ma L; Zhai L; Chen D; Li Y; Shang Z; Zhang Z; Gao Y; Yang W; Li Y; Pan Y
Int J Med Sci; 2021; 18(4):984-999. PubMed ID: 33456356
[TBL] [Abstract][Full Text] [Related]
19. Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma.
Liu GM; Zeng HD; Zhang CY; Xu JW
Cancer Cell Int; 2019; 19():138. PubMed ID: 31139015
[TBL] [Abstract][Full Text] [Related]
20. Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis.
Yan Z; He M; He L; Wei L; Zhang Y
Front Immunol; 2021; 12():723271. PubMed ID: 34925311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]